BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 19475864)

  • 41. Nurses are key to sickle cell screening.
    Anionwu E
    Nurs Times; 2004 Aug 31-Sep 6; 100(35):18. PubMed ID: 15471262
    [No Abstract]   [Full Text] [Related]  

  • 42. Red blood cell disorders in Rwandese neonates: screening for sickle cell disease and glucose-6-phosphate dehydrogenase deficiency.
    Munyanganizi R; Cotton F; Vertongen F; Gulbis B
    J Med Screen; 2006; 13(3):129-31. PubMed ID: 17007653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sickle cell anemia in Garasia tribals of Rajasthan.
    Mandot S; Khurana VL; Sonesh JK
    Indian Pediatr; 2009 Mar; 46(3):239-40. PubMed ID: 19179738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Newborn screening for sickle cell disease in a Nigerian hospital.
    Odunvbun ME; Okolo AA; Rahimy CM
    Public Health; 2008 Oct; 122(10):1111-6. PubMed ID: 18486954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sickle cell disease in North Europe.
    Howard J; Davies SC
    Scand J Clin Lab Invest; 2007; 67(1):27-38. PubMed ID: 17365983
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Neonatal screening for sickle cell disease].
    Farriaux JP
    Ann Biol Clin (Paris); 2003; 61(4):376-8. PubMed ID: 12915346
    [No Abstract]   [Full Text] [Related]  

  • 47. Screening for genetic traits and diseases.
    McCormack MK
    Am Fam Physician; 1981 Oct; 24(4):153-66. PubMed ID: 6792891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Neonatal screening for sickle cell anemia in metropolitan France. For the group for neonatal screening of sickle cell anemia of the French Association for Screening and Prevention of Infant Handicaps (AFDPHE)].
    Galactéros F
    Pathol Biol (Paris); 1999 Jan; 47(1):13-8. PubMed ID: 10081774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Sickle cell disease: exotic disease or a Belgian public health problem?].
    Gulbis B; Ferster A; Kentos A; N'Gay Munungi D; Cotton F; Rongé E; Dresse MF; Bradstreet C; Cochaux P; Vertongen F
    Rev Med Brux; 2005 Sep; 26(4):S309-13. PubMed ID: 16240879
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identifying homozygous sickle cell disease when neonatal screening is not available: a clinic-based observational study.
    Hambleton IR; Wierenga KJ
    J Med Screen; 2004; 11(4):175-9. PubMed ID: 15563773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A center in Paris for screening and counselling sickle cell patients and carriers].
    Tchernia G; Bardakdjian J; Lainé A; Ly A; Orssaud G; Larnaudie S
    Bull Acad Natl Med; 2008 Oct; 192(7):1349-59; discussion 1359-60. PubMed ID: 19445361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implementation of the newborn screening programme for sickle cell disease in England: results for 2003-2005.
    Streetly A; Clarke M; Downing M; Farrar L; Foo Y; Hall K; Kemp H; Newbold J; Walsh P; Yates J; Henthorn J
    J Med Screen; 2008; 15(1):9-13. PubMed ID: 18416948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Initially misleading communication of carrier results after newborn genetic screening.
    La Pean A; Farrell MH
    Pediatrics; 2005 Dec; 116(6):1499-505. PubMed ID: 16322177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term follow-up of children with sickle cell disease diagnosed by newborn screening in the Netherlands: Overview of morbidity and mortality.
    Vuong C; Eckhardt CL; Heijboer H; Suijker MH; de Ligt LA; Voigt ALA; Leeflang MMG; Bartels M; Brons P; Hooimeijer L; Rettenbacher E; Smiers FJ; Stein-Wit MA; van der Veer A; Verbaan A; Cnossen MH; Fijnvandraat K
    Am J Hematol; 2024 Aug; 99(8):1606-1609. PubMed ID: 38682156
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical and molecular characterization of hemoglobin Maputo [beta 47 (CD6) Asp > Tyr HBB: c.142G > T] and G-Ferrara [beta 57 (E1) Asn > Lys HBB: c.174C > A] in a newborn screening in Brazil.
    Silva MR; Sendin SM; Araujo IC; Pimentel FS; Viana MB
    Int J Lab Hematol; 2013 Dec; 35(6):e1-4. PubMed ID: 23279838
    [No Abstract]   [Full Text] [Related]  

  • 56. Prevalence of sickle cell disease among Grenadian newborns.
    Antoine M; Lee K; Donald T; Belfon Y; Drigo A; Polson S; Martin F; Mitchell G; Etienne-Julan M; Hardy-Dessources MD
    J Med Screen; 2018 Mar; 25(1):49-50. PubMed ID: 29183229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sickle cell disease in the UK.
    Darbyshire P
    Practitioner; 1990 Jul; 234(1492):722-6. PubMed ID: 2217072
    [No Abstract]   [Full Text] [Related]  

  • 58. [Extensive neonatal heel injection screening for metabolic diseases in the Netherlands].
    Visser G; van Spronsen FJ; de Sain-van der Velden MG; Blom HJ; Wijburg FA
    Ned Tijdschr Geneeskd; 2009 May; 153(18):848-53. PubMed ID: 19475862
    [No Abstract]   [Full Text] [Related]  

  • 59. Neonatal screening for sickle cell disease in France: evaluation of the selective process.
    Thuret I; Sarles J; Merono F; Suzineau E; Collomb J; Lena-Russo D; Levy N; Bardakdjian J; Badens C
    J Clin Pathol; 2010 Jun; 63(6):548-51. PubMed ID: 20498028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sickle cell disease and health education.
    Kirk SA
    Midwife Health Visit Community Nurse; 1987 May; 23(5):200-6. PubMed ID: 3649554
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.